Mepolizumab (SB 240563) is a humanized monoclonal antibody that binds to and neutralizes interleukin-5 (IL-5), the major cytokine involved in eosinophil proliferation, activation, and survival. Mepolizumab can be used for the research of eosinophilic granulomatosis with polyangiitis (EGPA) and severe eosinophilic asthma.
Purity:
98.0%
CAS Number:
[196078-29-2]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted